About Cytovation
The power of immunotherapy can be directed at multiple diseases – from benign tumors to malignant cancers. CyPep-1 is a first-in-class tumor membrane targeted immunotherapy for the treatment of solid tumors.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Round
Global Headquarters
Bergen, Norway
Tracked Since
Nov 8, 2026
Web & Domain Identity
Official Website
cytovation.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@cytovation
(179 followers)
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $6,000,000 · Round
fundraisingfox.com
- Capital Raise
Raised $8,000,000 · Series-A
fundraisingfox.com
Investors & Backers
Canica
Sandwater
Funding History
Round equity
· Apr 23, 2025
$6,000,000 fundraisingfox.com
Series-A equity
· Jun 2, 2023
$8,000,000 fundraisingfox.com
Founders & Leadership
Lars Prestegarden
co-founder and Chief Executive Officer (CEO)
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026